Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Lydaxx 100mg/ml solution recalled over sterility concerns
The recall affects a single batch of Lydaxx 100mg/ml solution for cattle, pigs and sheep.
Product may be compromised owing to crimping of the aluminium cap.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for Lydaxx 100mg/ml solution for cattle, pigs and sheep following sterility concerns.

The recall affects a single batch of the product -
Batch No.0C3829 Expiry Date 03/12/2022 - manufactured by Vetoquinol UK Ltd.

The recall states: “We wish to make wholesalers and veterinary surgeons aware that Vetoquinol UK Ltd has initiated a Class I recall of Lydaxx 100 mg/ml solution for injection for cattle, pigs and sheep as a precautionary measure.

“Vetoquinol have identified that there is a potential for the sterility/stability of the product to be compromised due to a crimping problem of the aluminium cap. This recall is for the 100 ml bottles of the following batch only: Batch No.0C3829 Expiry Date 03/12/2022."

Veterinary surgeons and wholesale dealers are being contacted by Vetoquinol UK Ltd to examine their inventory immediately and quarantine products subject to this recall.

More information about the recall can be obtained from Vetoquinol’s Customer Services Department on +44 1280 814500 Option 1 or email: UK_office@vetoquinol.com

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'